| Literature DB >> 9554244 |
I S Fraser1, A Tiitinen, B Affandi, V Brache, H B Croxatto, S Diaz, J Ginsburg, S Gu, P Holma, E Johansson, O Meirik, D R Mishell, H A Nash, B von Schoultz, I Sivin.
Abstract
This review has highlighted the attributes of a very important new method of contraception. The signatories to this document agree that, with the provision of appropriate information and instruction for the user, Norplant is a good contraceptive choice to be made available worldwide in family planning programs that have the resources for appropriate training and counseling. The signatories to this document are acting in their own personal capacity and not as representatives of any particular organization.Keywords: Clinic Activities; Contraception; Contraception Continuation--determinants; Contraception Termination; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--pharmacodynamics; Contraceptive Agents--side effects; Contraceptive Implants; Contraceptive Methods; Contraceptive Usage; Counseling; Developing Countries; Education; Family Planning; Family Planning Programs; Informed Consent; Levonorgestrel--pharmacodynamics; Levonorgestrel--side effects; Literature Review; Organization And Administration; Program Activities; Programs; Training Activities; Training Programs; World
Mesh：
Substances：
Year: 1998 PMID： 9554244 DOI： 10.1016/s0010-7824(97)00200-x
Source DB: PubMed Journal: Contraception ISSN： 0010-7824 Impact factor: 3.375